The Aston Research Centre for Health in Ageing (ARCHA) at Aston University has received £400,000 in funding to recruit four PhD students for a dementia research programme.
Subclonal neoantigens present a key roadblock in MMRd tumor immunotherapy success
Researchers evaluated sensitivity to immune checkpoint blockade (ICB) therapy.